Women's Health News

RSS

Flo; Much more than a period tracker

In this interview, we speak to Sonia Ponzo, the Director of Science at Flo Health, about their app and how it's revolutionizing the field of women's health.

From Flo Health 22 Mar 2022

Waning antibody responses in SARS-CoV-2-infected or vaccinated population

A recent study posted to the bioRxiv* preprint server evaluated the effects of the waning of antibodies after coronavirus disease 2019 (COVID-19) infection or vaccination.

22 Mar 2022

Factors influencing Australian mothers to vaccinate kids against COVID-19, get tested, and self-isolate

A new study investigates whether family demographic factors were associated with mothers’ willingness to vaccinate their four-year-old children.

21 Mar 2022

Coronavirus infection during pregnancy may double the risk of poor outcomes

A Kaiser Permanente analysis of pregnant patients who tested positive for the coronavirus found more than double the risk of poor outcomes including preterm birth, venous thromboembolism (blood clot), and severe maternal morbidity, which includes conditions such as acute respiratory distress syndrome and sepsis.

21 Mar 2022

Low levels of SARS-CoV-2 viremia associated with ‘COVID placentitis’ and stillbirths

Researchers hypothesize that patients with COVID placentitis were more likely to contract viremia.

20 Mar 2022

Sex-specific differences in T-cell responses to COVID-19

Researchers evaluate both neutralizing activity and T-cell responses in SARS-CoV-2 infected individuals with mild symptoms linked to a single spreading event.

20 Mar 2022

Trial shows safety and immunogenicity of immunotherapy with chemoradiation in cervical cancer patients

A Phase I/Ib trial conducted by the National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group NRG Oncology, NRG-GY017, concluded that the addition of the immunotherapy drug atezolizumab prior to and concurrently given with chemoradiation (CRT) treatment was safe for women with node-positive, locally advanced cervical cancer.

19 Mar 2022

HRR mutational status associated with survival outcomes in recurrent platinum-sensitive ovarian cancer

Results of a biomarker analysis of the NRG Oncology NRG-GY004 trial were presented at a Seminal Session during the Society for Gynecologic Oncology's (SGO) Annual Meeting on Women's Cancer in March 2022.

19 Mar 2022

Combination therapy shows promising results in patients with recurrent ER-positive endometrial cancer

A combination therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in 75% of patients with recurrent or persistent estrogen receptor- (ER-) positive endometrial cancer, results from a recent clinical trial show.

19 Mar 2022

Women less likely to receive lifesaving intervention for cardiogenic shock than men

Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to research presented today at ESC Acute CardioVascular Care 2022, a scientific congress of the European Society of Cardiology.

19 Mar 2022

New approach radically increases the success of breast cancer immunotherapy

A study published in the journal Nature Cancer, carried out within the Cancer Programme at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) by the Cancer Stem Cells and Metastasis Dynamics Laboratory, led by Dr. Toni Celià-Terrassa, and the Laboratory of Molecular Cancer Therapy, coordinated by Dr. Joan Albanell, with the participation of international centers, has discovered an approach that radically increases the success of immunotherapy in one of the most aggressive types of tumors, triple-negative breast cancer.

17 Mar 2022

Risk of SARS-CoV-2 transmission from mother to baby is extremely low, say researchers

Less than 2% of babies born to mothers with SARS-CoV-2 (the virus responsible for covid-19 infection) also test positive around the time of birth, finds an analysis of the latest evidence published by The BMJ today.

17 Mar 2022

The effects of anti-SARS-CoV-2 monoclonal antibodies on pregnant and postpartum women

Researchers examine the safety and efficacy of mAbs in pregnant and postpartum women with COVID-19.

16 Mar 2022

Study clarifies sex-based burdens during the pandemic, raises awareness for menstrual equity

Income loss was a strong predictor of menstrual product insecurity across the U.S. during COVID-19, and populations with lower incomes and the lowest educational attainment were most vulnerable, according to a new study conducted by Columbia University Mailman School of Public Health in partnership with the CUNY School of Public Health.

16 Mar 2022

Blood test may identify risk of stillbirth and placentitis in pregnant patients with COVID-19

A small preliminary study from Northwestern Medicine has shown that a blood test may identify risk of stillbirth and placentitis in pregnant individuals who have had COVID-19.

16 Mar 2022

Maternal and neonatal outcomes during UK's SARS-CoV-2 Omicron wave

Researchers describe the characteristics of pregnant women hospitalized due to COVID-19.

15 Mar 2022

Researchers investigate loss of fitness following COVID-19

Researchers investigate if a decline in exercise capabilities is due to deconditioning during infection or long-term reductions in ability due to COVID-19.

15 Mar 2022

Women’s health services yet to recover from COVID-19 disruptions

Women's health services are far from fully being restored following disruptions caused by the COVID-19 pandemic, the World Health Organization (WHO) says.

15 Mar 2022

Research findings may explain marked racial disparity in deaths from triple negative breast cancer

Different activity in two molecular networks could help explain why triple negative breast cancers tend to be more aggressive in African American (AA) women compared with white American (WA) women, a new study led by Johns Hopkins Kimmel Cancer Center researchers suggests.

15 Mar 2022

Routine mammograms may provide clues for heart disease risk in postmenopausal women

Routine mammograms may provide key insights for cardiovascular disease. Detection of breast arterial calcifications on breast mammograms was associated with a higher risk of cardiovascular disease in postmenopausal women, according to new research published today in Circulation: Cardiovascular Imaging, a peer-reviewed journal of the American Heart Association journal.

15 Mar 2022

Women's Health News

Flo; Much more than a period tracker

Waning antibody responses in SARS-CoV-2-infected or vaccinated population

Factors influencing Australian mothers to vaccinate kids against COVID-19, get tested, and self-isolate

Coronavirus infection during pregnancy may double the risk of poor outcomes

Low levels of SARS-CoV-2 viremia associated with ‘COVID placentitis’ and stillbirths

Sex-specific differences in T-cell responses to COVID-19

Trial shows safety and immunogenicity of immunotherapy with chemoradiation in cervical cancer patients

HRR mutational status associated with survival outcomes in recurrent platinum-sensitive ovarian cancer

Combination therapy shows promising results in patients with recurrent ER-positive endometrial cancer

Women less likely to receive lifesaving intervention for cardiogenic shock than men

New approach radically increases the success of breast cancer immunotherapy

Risk of SARS-CoV-2 transmission from mother to baby is extremely low, say researchers

The effects of anti-SARS-CoV-2 monoclonal antibodies on pregnant and postpartum women

Study clarifies sex-based burdens during the pandemic, raises awareness for menstrual equity

Blood test may identify risk of stillbirth and placentitis in pregnant patients with COVID-19

Maternal and neonatal outcomes during UK's SARS-CoV-2 Omicron wave

Researchers investigate loss of fitness following COVID-19

Women’s health services yet to recover from COVID-19 disruptions

Research findings may explain marked racial disparity in deaths from triple negative breast cancer

Routine mammograms may provide clues for heart disease risk in postmenopausal women

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News